RITUXIMAB RITUXIMAB (13095F) rituximab 500 mg/50 mL injection, 50 mL vial 13095F Body System: Antineoplastic And Immunomodulating Agents > Antineoplastic Agents > Monoclonal Antibodies And Antibody Drug Conjugates Manner of administration:Injection Private S100 HSD Private No restrictions Quantities & Cost Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge Max qty packs: 2 Max qty units: 2 # of repeats: 1 DPMQ: $458.54 Max safety net: $25.00 General Patient Charge: $25.00 Available brands Riximyo Ruxience Truxima RITUXIMAB (13101M) rituximab 500 mg/50 mL injection, 50 mL vial 13101M Body System: Antineoplastic And Immunomodulating Agents > Antineoplastic Agents > Monoclonal Antibodies And Antibody Drug Conjugates Manner of administration:Injection Public S100 HSD Public No restrictions Quantities & Cost Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge Max qty packs: 2 Max qty units: 2 # of repeats: 1 DPMQ: $432.36 Max safety net: $25.00 General Patient Charge: $25.00 Available brands Riximyo Ruxience Truxima